Filing Flows › Companies › Hanover Bancorp › Cash flow
Hanover Bancorp cash flow, quarter by quarter
Latest: Q3 2026 · from the cash-flow statements filed with the SEC
Free cash flow$14.7M in Q3 2026 · $38.0M over twelve months
Analysis
In Q3 2026, Hanover Bancorp generated $15.0M of operating cash flow and spent $275K on capital projects, leaving free cash flow of $14.7M. That is $12.3M more than in Q3 2025 ($2.4M).
Over the twelve months to Sep 30, 2026, operating cash flow was $39.2M; the largest uses were other investing ($158M), buybacks ($6.1M), dividends ($3.0M); besides operations, cash came from other financing ($104M); the cash balance fell by $25.0M.
Operating cash flow was $15.0M against net income of $4.3M — 3.4× profit, cash ran ahead of reported earnings. The largest differences: other liabilities +$7.8M, prepaid and other assets +$1.2M, depreciation & amortization +$497K.
Free cash flow
Where the cash came from and went
From profit to cash
Every quarter
| Quarter | Operating cash flow | Capital spending | Buybacks | Dividends | Cash drawn (+) / kept (−) | Free cash flow |
|---|---|---|---|---|---|---|
| Q3 2026 | $15.0M | −$275K | −$2.2M | −$731K | −$1.3M | $14.7M |
| Q2 2026 | $18.4M | −$442K | — | −$742K | $53.2M | $18.0M |
| Q1 2026 | −$2.5M | −$184K | — | −$746K | $14.5M | −$2.7M |
| Q4 2025 | $8.2M | −$234K | −$1.3M | −$762K | −$41.3M | $8.0M |
| Q3 2025 | $2.7M | −$317K | — | −$748K | −$3.0M | $2.4M |
| Q2 2025 | $1.8M | −$90K | — | −$750K | −$4.3M | $1.7M |
| Q1 2025 | $284K | −$228K | — | −$749K | $2.6M | $56K |
| Q4 2024 | $5.5M | $789K | — | −$742K | −$21.6M | $6.3M |
Hanover Bancorp: income statement and cash flow
Hanover Bancorp, Q3 2026: revenue $19.3M (+7% year over year), operating margin 30.0%. The chart follows the revenue to costs, profit and cash.
Hanover Bancorp: every quarter, Q/Q and Y/Y → Open in the app
Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.